Cardiac metabolism in myocardial ischemia

Current Pharmaceutical Design

Volumn 14, Issue 25, 2008, Pages 2551-2562

  Rosano, Giuseppe M C ^a   Fini, Massimo ^a   Caminiti, Giuseppe ^a   Barbaro, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Beta oxidation; Cardiac metabolism; Glycolysis; Myocardial ischemia; Oxidative phosphorylation

Indexed keywords

1 PHOSPHOFRUCTOKINASE; ACETYL COENZYME A ACYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE; ESTROGEN RELATED RECEPTOR ALPHA; FATTY ACID; FATTY ACID BINDING PROTEIN; GLUCOSE; HEAT SHOCK PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSULIN; LONG CHAIN FATTY ACID COENZYME A LIGASE; MALONYL COENZYME A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PYRUVATE DEHYDROGENASE COMPLEX; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

CELL DEATH; CHRONIC DISEASE; CITRIC ACID CYCLE; DISEASE SEVERITY; ENERGY BALANCE; ENERGY METABOLISM; ENZYME REGULATION; FATTY ACID OXIDATION; GENE EXPRESSION; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HUMAN; MYOCARDIAL HIBERNATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW;

ANIMALS; ENERGY METABOLISM; GLYCOLYSIS; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIUM;

EID: 57349141429     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208786071317     Document Type: Review

References (163)

1. Opie L. The Heart: Physiology, from cell to circulation. Philadelphia, Lippincott-Raven, 1998.
2. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions: potential for pharmacological interventions. Cardiovasc Res 1997; 33: 243-57.
3. Hinkle PC, Kumar MA, Resetar A, Harris DL. Mechanistic stoichiometry of mitochondrial oxidative phosphorylation. Biochemistry 1991; 30: 3576-82.
4. Ferrari R. Metabolic disturbances during myocardial lschemia and reperfusion. Am J Cardiol l995; 76: 17B-24B.
5. Taegtmeyer H, Roberts AFC, Rayne AEG. Energy metabolism in reperfusedrat heart: return of function before normalization of ATP content. J Am Coll Cardiol 1985; 6: 864-70.
6. Taegtmeyer H, Hems R, Krebs HA. Utilization of energy providing substrates in the isolated working rat heart. Biochem J 1980; 186: 701-11.
7. Taegtmeyer H, King LM, Jones BJ. Energy Substrate Metabolism, Myocardial Ischemia, and Targets for Pharmacotherapy Am J Cardiol 1998; 82: 54K-60K.
8. Bessman SP, Geiger PJ. Transport of energy in muscle: the phosphorylcreatine shuttle. Science 1981; 211: 448-52.
9. Ingwall JS. ATP and the heart. Norwell, MA: Kluwer Academic, 2002.
10. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 1992; 281: 21-40.
11. Guimbal C, Kilimann MWA. A Na(+)- dependent creatine transporter in rabbit brain, muscle, heart, and kidney: cDNA cloning and functional expression. J Biol Chem 1993; 268: 8418-21.
12. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1(7285): 785-9.
13. Taegtmeyer H, Roberts AFC, Rayne AEG. Energy metabolism in reperfused rat heart: return of function before normalization of ATP content. J Am Coll Cardiol 1985; 6: 864-70.
14. Richieri GV, Anel A, Kleinfeld AM. Interactions of long-chain fatty acids and albumin: determination of free fatty acid levels using the fluorescent probe ADIFAB. Biochemistry 1993; 32: 7574-80.
15. De Jong J.W, Hülsmann WC. A comparative study of palmitoyl-CoA synthetase activity in rat-liver, heart and gut mitochondrial and microsomal preparations. Biochim Biophys Acta 1970; 197: 127-35.
16. Declercq PE, Falck JR, Kuwajima M, Tyminski H, Foster DW, McGarry JD. Characterization of the mitochondrial carnitine palmitoyltransferase enzyme system. I. Use of inhibitors. J Biol Chem 1987; 262, 9812-21.
17. Stanley W, Chandler MP. Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev. 2002; 7: 115-30.
18. Goodwin GW, Taylor CS, Taegtmeyer H. Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem 1998; 273: 29530-9.
19. Fraser F, Corstorphine CG, Zammit VA. Topology of carnitine palmitoyltransferase I in the mitochondrial outer membrane. Biochem J 1997; 323: 711-8.
20. Rasmussen BB, Holmbäck UC, Volpi E, Morio-Liondore B, Paddon- Jones D, Wolf R. Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. J Clin Investig 2002; 110: 1687-93.
21. Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev 2006; 86: 205-43.
22. Jensen MD. Fatty acid oxidation in human skeletal muscle. J Clin Investig 2002; 11: 1607-9.
23. Rubink DS, Winder WW. Effect of phosphorylation by AMPactivated protein kinase on palmitoyl-CoA inhibition of skeletal muscle acetyl-CoA carboxylase. J Appl Physiol 2005; 98: 1221-7.
24. Chen ZP, McConnell GK, Michell BJ, Snow RJ, Canny BJ, Kemp BE. AMPK signaling in contracting human skeletal muscle: acetyl- CoA carboxylase and NO synthase phosphorylation. Am J Physiol Endocrinol Metab 2000; 279: E1202-6.
25. Gould GW, Holman GD. The glucose transporter family: structure, function and tissue-specific expression. Biochem J 1993; 295: 329-41.
26. Santalucia T, Boheler KR, Brand NJ, Sahye U, Fandos C, Vinals F, et al. Factors involved in GLUT-1 glucose transporter gene transcription in cardiac muscle. J Biol Chem 1999; 274: 17626-34.
27. Broderick TL, Quinney HA, Lopaschuk GD. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 199; 2267: 3758-63.
28. Nascimben L, Ingwall JS, Lorell BH, Pinz I, Schultz V, Tornheim K, et al. Mechanisms for increased glycolysis in the hypertrophied rat heart. Hypertension 2004; 44: 662-7.
29. Tian R, Musi N, D'Agostino J, Hirshman MF, Goodyear LJ. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 2001; 104: 1664-9.
30. Behal RH, Buxton DB, Robertson JG, Olson MS. Regulation of the pyruvate dehydrogenase multienzyme complex. Ann Rev Nutr 1993; 13: 497-520.
31. Chi NC, Karliner JS. Molecular determinants of responses to myocardial ischemia/reperfusion injury: focus on hypoxia-inducible and heat shock factors. Cardiovasc Res 2004; 61: 437-47.
32. Semenza GL. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp Physiol 2006; 91: 803-6.
33. Kaczmarczyk SJ, Andrikopoulos S, Favaloro J, Domenighetti AA, Dunn A, Ernst M, et al. Threshold effects of glucose transporter-4 (GLUT4) deficiency on cardiac glucose uptake and development of hypertrophy. J Mol Endocrinol 2003; 31: 449-59.
34. Degens H, de Brouwer KF, Gilde AJ, Lindhout M, Willemsen PH, Janssen BJ, et al. Cardiac fatty acid metabolism is preserved in the compensated hypertrophic rat heart. Basic Res Cardiol 2006; 101: 17-26.
35. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α-β and-γ in the adult rat. Endocrinology 1996; 137: 354-66.
36. Escher P, Braissant O, Basu-Modak S, Michalik L, Wahli W, Desvergne B. Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 2001; 142: 4195- 202.
37. Djouadi F, Brandt JM, Weinheimer CJ, Leone TC, Gonzalez FJ, Kelly DP. The role of the peroxisome proliferator-activated receptor α (PPAR α) in the control of cardiac lipid metabolism. Prostaglandins Leukot Essent Fat Acids 1999; 60: 339-43.
38. Panagia M, Gibbons GF, Radda GK, Clarke K. PPAR-α activation required for decreased glucose uptake and increased susceptibility to injury during ischemia Am J Physiol 2005; 288: H2677-83.
39. Sambandam N, Morabito D, Wagg C, Finck BN, Kelly DP, Lopaschuk GD. Chronic activation of PPARα is detrimental to cardiac recovery after ischemia. Am J Physiol 2006; 290: H87-H95.
40. Campbell FM, Kozak RA, Wagner A. A role for peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARα are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase. J Biol Chem 2002; 277: 4098-103.
41. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, et al. The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. J Clin Investig 2002; 109: 121-30.
42. Finck BN, Han X, Courtois M, Aimond F, Nerbonne JM, Kovacs A, et al. A crical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc Natl Acad Sci USA 2003; 100: 1226-31.
43. Harris IS, Treskov I, Rowley MW, Heximer S, Kaltenbronn K, Finck BN, et al. G-protein signalling participates in the development of diabetic cardiomyopathy. Diabetes 2004; 53: 3082-90.
44. Park SY, Cho YR, Finck BN, Kim HJ, Higashimori T, Hong EG, et al. Cardiacspecific overexpression of peroxisome proliferatoractivated receptor-α causes insulin resistance in heart and liver. Diabetes 2005; 54: 2514-24.
45. Giguere V, Yang N, Segui P, Evans RM. Identification of a new classof steroid hormone receptors. Nature 1988; 331: 91-4.
46. Hong H, Yang L, Stallcup MR. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J Biol Chem 1999; 274: 22618-26.
47. Heard DJ, Norby PL, Holloway J, Vissing H. Human ERRγ, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult. Mol Endocrinol 2000; 14: 382-92.
48. Huss JM, Torra IP, Staels B, Giguere V, Kelly DP. Estrogenrelatedreceptor α directs peroxisome proliferator-activated receptor α signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol Cell Biol 2004; 24: 9079-91.
49. Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metabolism 2005; 1: 361-37.
50. Finck BN, Kelly DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Investig 2006; 116: 615-22.
51. Boss O, Bachman E, Vidal-Puig A, Zhang CY, Peroni O, Lowell BB. Role of the β3-adrenergic receptor and/or a putative β4-adrenergic receptor on the expression of uncoupling proteins and peroxisome proliferator-activated receptor-γ coactivator-1. Biochem Biophys Res Commun 1999; 261: 870-76.
52. Fan M, Rhee J, St-Pierre J, Handschin C, Puigserver P, Lin J, et al. Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1α: modulation by p38 MAPK. Genes Dev 2004; 18: 278-89.
53. Nisoli E, Falcone S, Tonello C, Cozzi V, Palomba L, Fiorani M, et al. Mitochondrial biogenesis byNOyields functionally active mitochondria in mammals. Proc Natl Acad Sci USA 2004; 101: 16507-12.
54. Hacker TA, Renstrom B, Nellis SH, Liedtke AJ. Effect of repetitive stunning on myocardial metabolism in pig hearts. Am J Physiol Heart Circ Physiol 1997; 273: H1395-402.
55. Denton RM, McCormack JG. On the role of the calcium transport cycle in the heart and other mammalian mitochondria. FEBS Lett 1980; 119: 1-8.
56. Samaja M, Allibardi S, Milano G, Neri G, Grassi B, Gladden LB, et al. Differential depression of myocardial function and metabolism by lactate and H+. Am J Physiol 1999; 276: H3-8.
57. McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in reper-fusion of mammalian intramitochondrial metabolism. Physiol Rev 1990; 70: 391- 425.
58. Kubler W. Myocardial energy metabolism in patients with ischemic heart disease. Basic Res Cardiol 1974; 79: 105-112.
59. +, and lactate in ischemic heart. Anal Biochem 2002; 308: 52-60.
60. Rovetto MJ, Lamberton WF, Neely JR. Mechanisms of glycolytic inhibition in ischemic rat hearts. Circ Res 1975; 37: 742-51.
61. Taegtmeyer H. Metabolic responses to cardiac hypoxia: increased production of succinate by rabbit papillary muscles. Circ Res 1978; 43: 808-15.
62. Cross H, Clarke K, Opie L, Radda GK. Is lactate-induced myocardial ischaemic injury mediated by decreased pH or increased intracellular lactate? J Mol Cell Cardiol 1995; 27: 1369-81.
63. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994; 1213: 263-76.
64. Lopaschuk GD, MA. Glucose and palmitate oxidation during reperfusion of ischemic hearts from diabetic rats. Diabetic Heart 1991; 451-64.
65. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 1997; 33: 243-57.
66. Mueller HS, Ayres SM. Metabolic response of the heart in acute myocardial infarction in man. Am J Cardiol 1978; 42: 363-71.
67. Oliver MF, Kurien VA, Greenwood TW. Relation between serumfree- fatty acids and arrhythmias and death after acute myocardial infarction. Lancet 1968; 1: 710-4.
68. Opie LH. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size. Am J Cardiol 1975; 36: 938-53.
69. Kudo NB, Barr A, Barr R, Lopaschuk GD. 5-AMP-activated protein kinase inhibition of acetyl CoA carboxylase can explain the high rates of fatty acid oxidation in reperfused ischemic hearts. J Biol Chem 1995; 270: 17511-20.
70. Thakker GD, Frangogiannis NG, Bujak M, Zymek P, Gaubatz JW, Reddy AK, et al. Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol 2006; 291: H2504-14.
71. Dyck JR, Berthiaume LG, Thomas PD, Kantor PF, Barr AJ, Barr R, et al. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism. Biochem J 2000; 350: 599-608.
72. Gamble J, Lopaschuk GD. Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats. Biochim Biophys Acta 1994; 1225: 191-199.
73. Sakamoto J, Barr RL, Kavanagh KM, Lopaschuk GD. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart. Am J Physiol Heart Circ Physiol 2000; 278: H1196-204.
74. Liedtke AJ, DeMaison L, Eggleston AM, Cohen LM, Nellis SH. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ Res 1988; 62: 535-42.
75. Lopaschuk GD, Saddik M, Barr R, Huang L, Barker CC, Muzyka RA. Effects of high levels of fatty acids on functional recovery of ischemic hearts from diabetic rats. Am J Physiol 1992; 263: E1046-53.
76. Lopaschuk GD, Spafford MA, Davies NJ, Wall SR. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. Circ Res 1990; 66: 546-53.
77. Folmes CDL, Clanachan AS, Lopaschuk GD. Fatty Acids attenuate insulin regulation of 5-AMP-activated protein kinase and insulin cardioprotection after ischemia. Circ Res 2006; 99: 61- 8.
78. Liu B, Clanachan AS, Schulz R, Lopaschuk GD. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circ Res 1996; 79: 940-8.
79. Liu B, el Alaoui-Talibi Z, Clanachan AS, Schulz R, Lopaschuk GD. Uncoupling of contractile function from mitochondrial TCA cycle activity and MVO2 during reperfusion of ischemic hearts. Am J Physiol 1996; 270: H72-80.
80. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 1991; 122: 795-801.
81. Tian R, Musi N, D'Agostino J, Hirshman MF, Goodyear LJ. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 2001; 104: 1664-9.
82. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 2000; 10: 1247-55.
83. Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 1997; 273: E1107-12.
84. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999; 98: 115-24.
85. St Pierre J, Lin J, Krauss S, Tarr PT, Yang R, Newgard CB et al. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem 2003; 278: 26597-603.
86. Derek M, Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Eng J Med 2007; 357: 1121-35.
87. Bolli R, Becker L, Gross G, Mentzer R Jr, Balshaw D, Lathrop DA. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 2004; 95: 125- 34.
88. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998; 38: 291-300.
89. Downey JM. Free radicals and their involvement during long-term myocardial ischemia and reperfusion. Annu Rev Physiol 1990; 52: 487-504.
90. ChenQ, Camara AKS, Stowe DF, Hoppel CL, Lesnefsky EJ. Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am J Physiol Cell Physiol 2007; 292: C137-47.
91. Chen Q, Hoppel CL, Lesnefsky EJ. Reperfusion with preserved mitochondrial function decreases mitochondrial hydrogen peroxide production and infarct size (Abstract). FASEB J 2006; 20: A318.
92. ChenQ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion. Pharmacol Exp Ther 2006; 319: 1405-12.
93. Lesnefsky EJ, Slabe TJ, Stoll MS, Minkler PE, Hoppel CL. Myocardial ischemia selectively depletes cardiolipin in rabbit heart subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 2001; 280: H2770-8.
94. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA 2002; 99: 1259-63.
95. Ravingerova T. Intrinsic defensive mechanisms in the heart: a potential novel approach to cardiac protection against ischemic injury. Gen Physiol Biophys 2007; 26: 3-13.
96. Bolli R. Oxygen-derived free radicals and myocardial reperfusion injury: An overview 2004; 5: 249-68.
97. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: H579-88.
98. Cohen MV, Yang XM, Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation 2007; 115: 1895-903.
99. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, et al. Postconditioning the human heart. Circulation 2005; 112: 2143-8.
100. Vinten-Johansen J, Zhao ZQ, Zatta AJ, Kin H, Halkos ME, Kerendi F. Postconditioning: a new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol 2005; 100: 295-310.
101. Vanoverschelde J, Depre C, Gerber BL, Borges M, Wijns W, Robert A, et al. Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol 2000; 85: 1432-9.
102. Diamond G, Forrester J, DeLuz P, Wyatt HL, Swan HL. Postextrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J 1978; 95: 204-9.
103. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985; 72: V123-35.
104. Rahimtoola S. The hibernating myocardium. Am Heart J 1989: 117: 211-21.
105. Fath-Ordoubadi F, Beatt KJ, Spyrou N,Camici PG. Efficacy of coronaryangioplasty for the treatment of hibernating myocardium. Heart 1999; 82: 210-6.
106. Vanoverschelde JL, D'Hondt AM, Marwick T, Gerber BL, De Kock M, Dion R, et al. Head-to-head comparison of exerciseredistribution- reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction. JACC 1996; 28: 432-42.
107. Camici PG, Wijns W, Borgers M, De Silva R, Ferrari R, Knuuti J, et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease. Circulation 1997; 96: 3205-14.
108. Fedele FA, Gewirtz H, Capone RJ, Sharaf B, Most AS. Metabolic response to prolonged reduction of myocardial blood flow distal to a severe coronary artery stenosis. Circulation 1988; 78: 729-35.
109. Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions. Circ Res 1991; 68: 466-81.
110. Arai AE, Pantely GA, Anselone CG, Bristow J, Bristow JD. Active downregulation of myocardial energy requirements during prolonged moderate ischemia in swine. Circ Res 1991; 69: 1458-69.
111. Chen C, Chen L, Fallon JT, Ma L, Li L, Bow L, et al. Functional and structural alterations with 24-hour myocardial hibernation and recovery after reperfusion. A pig model of myocardial hibernation. Circulation 1996; 94: 507-16.
112. Chen C, Ma L, Dyckman W, Santos F, Lai T, Gillam LD, et al. Left ventricular remodeling in myocardial hibernation. Circulation 1997; 96(Suppl II): 46-50.
113. Heusch G, Rose J, Skyschally A, Post H, Schulz R. Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart-inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation 1996; 93: 1556-66.
114. Schaefer S, Schwartz GG, Wisneski JA, Trocha SD, Christoph I, Steinman SK, et al. Response of high-energy phosphates and lactate during prolonged regional ischemia in vivo. Circulation 1992; 85: 342-9.
115. Neill WA, Ingwall JS, Andrews E, Gopal MA, Klein K, Kramer M, et al. Stabilization of a derangement in adenosine triphosphate metabolism during sustained, partial ischemia in the dog heart. J Am Coll Cardiol 1986; 8: 894-900.
116. Schaefer S, Carr LJ, Kreutzer U, Jue T. Myocardial adaptation during acute hibernation: mechanisms of phosphocreatine recovery. Cardiovasc Res 1993; 27: 2044-51.
117. Kroll K, Kinzie DJ, Gustafson LA. Open-system kinetics of myocardial phosphoenergetics during coronary underperfusion. Am J Physiol Heart Circ Physiol 1997; 41: H2563-76.
118. Pantely GA, Malone SA, Rhen WS, Anselone CG, Arai A, Bristow J, et al. Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia. Circ Res 1990; 67: 1481-93.
119. Schulz R, Guth BD, Pieper K, Martin C, Heusch G. Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery: a model of short-term hibernation. Circ Res 1992; 70: 1282-95.
120. Zhang J, Ishibashi Y, Zhang Y, Eijgelshoven MHJ, Duncker DJ, Merkle H, et al. Myocardial bioenergtics during acute hibernation. Am J Physiol Heart Circ Physiol 1997; 273: H1452-63.
121. Martin C, Schulz R, Rose J, Heusch G. Inorganic phosphate content and free energy change of ATP hydrolysis in regional shortterm hibernating myocardium. Cardiovasc Res 1998; 39: 318-26.
122. Fallavollita JA, Malm BJ, Canty JM Jr. Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest. Circ Res 2003; 92: 48-55.
123. McFalls EO, Baldwin D, Palmer B, Marx D, Jaimes D, Ward HB. Regional glucose uptake within hypoperfused swine myocardium as measured by positron emission tomography. Am J Physiol Heart Cir Physiol 1997; 41: H343-9.
124. Conversano A, Walsh JF, Geltman EM, Perez JE, Bergmann SR, Gropler RJ. Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease. Am Heart J 1996; 131: 440-50.
125. Czernin J, Porenta G, Brunken R, Krivokapich J, Chen K, Bennett R, et al. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. Circulation 1993; 88: 884-95.
126. Hata T, Nohara R, Fujita M, Hosokawa R, Lee L, Kudo T, et al. Noninvasive assessment of myocardial viability by positron emission tomography with 11C acetate in patients with old myocardial infarction. Usefulness of low-dose dobutamine infusion. Circulation 1996; 94: 1834-41.
127. Bristow JD, Arai AE, Anselone CG, Pantely GA. Response to myocardial ischemia as a regulated process. Circulation 1991; 84: 2580-7.
128. McNulty PH, Jagasia D, Cline GW, Ng CK, Whiting JM, Garg P, et al. Persistent changes in myocardial glucose metabolism in vivo during reperfusion of a limited-duration coronary occlusion. Circulation 2000; 101: 917-22.
129. Tamm C, Benzi R, Papageorgiou I, Tardy I, Lerch R. Substrate competition in postischemic myocardium. Effect of substrate availability during reperfusion on metabolic and contractile recovery in isolated rat hearts. Circ Res 1994; 75: 1103-12.
130. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 1981; 23: 321-36.
131. Gerber BL, Vanoverschelde J-LJ, Bol A, Michel C, Labar D, Wijns W, et al.. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996; 94: 651-9.
132. Mäki M, Luotolahti M, Nuutila P, Iida H, Voipio-Pulkki LM, Ruotsalainen U, et al. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996; 93: 1658-66.
133. Sun D, Nguyen N, DeGrado TR, Schwaiger M, Brosius FC. Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes. Circulation 1994; 89: 793-8.
134. Depre C, Vanoverschelde JL, Gerber B, Borgers M, Melin JA, Dion R. Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphologic features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1997; 113: 82-7.
135. Depre C, Kim SJ, John AS, Huang Y, Rimoldi OE, Pepper JR, et al. Program of cell survival underlying human and experimental hibernating myocardium. Circ Res 2004; 95: 433-40.
136. Liedtke AJ, Renstrom B, Nellis SH, Hall JL, Stanley WC. Mechanical and metabolic functions in pig hearts after 4 days of chronic coronary stenosis. J Am Col Cardiol 1995: 26: 815-25.
137. McNulty PH, Luba MC. Transient ischemia induces regional myocardial glycogen synthase activation and glycogen synthesis in vivo. Am J Physiol 1995; 268: H364-H370.
138. Allard MF, Schonekess BO, Henning SL, English DR, Lopaschuk GD. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol 1994; 267: H742-50.
139. Chiste ME, Rodgers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive Rat. J Mol Cell Cardiol 1994; 26: 1371-75.
140. Taegtmeyer H, Overturf ML. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension 1988; 11: 416-26.
141. Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 1998; 4: 1269-75.
142. Rosenblatt-Velin N, Montessuit C, Papageorgiou I, Terrand J, Lerch R. Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism. Cardiovasc Res 2001; 52: 407-16.
143. Liao R, Jain M, Cui L, D' Agostino J, Aiello F, Luptak I, et al. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation 2002; 106: 2125-31.
144. Sabbah HN, Chandler MP, Mishima T, Suzuki G, Chaudhry P, Nass O, et al. Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure. J Cardiac Fail 2002; 8: 416-22.
145. Sabbah HN, Stanley WC. Partial fatty acid oxidation inhibitors: a potentially new class of drugs for heart failure. Eur J Heart Fail 2002; 4: 3-6.
146. Stanley WC, Morgan EE, Chandler MP, Hoit BD. Up-regulation of the fatty acid oxidation (FAO) pathway does not exacerbate heart failure in rats. Cardiovasc J S Afr 2004; 15: S6-7.
147. Wayman NS, Ellis BL, Thiemermann C. Ligands of the peroxisome proliferator-activated receptor-PPAR-α reduce myocardial infarct size. Med Sci Monitor 2002; 8: BR243-47.
148. Yue TL, Bao W, Jucker BM, Gu JL, Romanic AM, Brown PJ, et al. Activation of peroxisome proliferator-activated receptor-α protects the heart from ischemia/reperfusion injury. Circulation 2003; 108: 2393-9.
149. Ichihara S, Obata K, Yamada Y, Nagata K, Noda A, Ichihara G, et al. Attenuation of cardiac dysfunction by a PPAR-α agonist is associated with down-regulation of redox-regulated transcription factors. J Mol Cell Cardiol 2006; 41: 318-29.
150. Watanabe K, Fujii H, Takahashi T, Kodama M, Aizawa Y, Ohta Y, et al. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor α associated with agedependent cardiac toxicity. J Biol Chem 2000; 275: 22293-9.
151. Luptak I, Balschi JA, Xing Y, Leone TC, Kelly DP, Tian R. Decreased contractile and metabolic reserve in peroxisome proliferator- activated receptor-α-null hearts can be rescued by increasing glucose transport and utilization. Circulation 2005; 112: 2339-46.
152. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004; 18: 1692-700.
153. Chiu H-C, A. Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Investig 2001; 107: 813-22.
154. Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ, et al. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 2005; 96: 225-33.
155. Kudej RK, White LT, Kudej AB, Vatner SF, Lewandowski ED. Brief increase in carbohydrate oxidation after reperfusion reverses myocardial stunning in conscious pigs. Circulation 2002; 106: 2836-41.
156. Kim SJ, Peppas A, Hong SK, Yang G, Huang Y, Diaz G, et al. Persistent stunning induces myocardial hibernation and protection Circ Res 2003; 92: 1233-39.
157. Lüss H, Schäfers M, Neumann J, Hammel D, Vahlhaus C, Baba HA, et al. Biochemical mechanisms of hibernation and stunning in the human heart. Cardiovasc Res 2002; 56: 411-21.
158. Luss H, Boknik P, Heusch G, Muller FU, Neumann J, Schimtz W, et al. Expression of calcium regulatory proteins in short-term hibernation and stunning in the in-situ porcine heart. Cardiovasc Res 1998; 37: 606-17.
159. Canty JM, Suzuki G, Banas MD, Verheyen F, Borgers M, Fallavollita JA. Hibernating myocardium: chronically adapted to ischemia but vulnerable to sudden death. Circ Res 2004; 94: 1142-49.
160. Shan K, Bick RJ, Poindexter BJ, Nagueh SF, Chimoni S, Verani MS, et al. Altered adrenergic receptor density in myocardial hibernation in humans: a possible mechanism of depressed myocardial function. Circulation 2000; 102: 2599-606.
161. Benchimol M. The hydrogenosome as a drug target. Curr Pharm Des 2008; 14(9): 872-81.
162. Braam B, Verhaar MC. Understanding eNOS for pharmacological modulation of endothelial function: a translational view. Curr Pharm Des 2007; 13(17): 1727-40.
163. Paschen W, Proud CG, Mies G. Shut-down of translation, a global neuronal stress response: mechanisms and pathological relevance. Curr Pharm Des 2007; 13(18): 1887-902.